MGO One Seven’s ClearPoint Neuro CLPT Stock Holding History

MGO One Seven’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$187K	Buy	20,516 +1,011	+5%	+$12.8K	﹤0.01%	1354
2025 Q4	$267K	Buy	19,505 +479	+3%	+$8.88K	0.01%	1159
2025 Q3	$415K	Buy	19,026 +1,077	+6%	+$12.7K	0.01%	885
2025 Q2	$214K	Buy	17,949 +1,569	+10%	+$19.7K	0.01%	1115
2025 Q1	$195K	Sell	16,380 -1,080	-6%	-$16.8K	0.01%	1034
2024 Q4	$269K	Buy	+17,460	New	+$226K	0.01%	888
2022 Q2	–	Sell	-10,293	Closed	-$107K	–	650
2022 Q1	$107K	Sell	10,293 -3,850	-27%	-$35K	0.01%	648
2021 Q4	$159K	Sell	14,143 -800	-5%	-$12K	0.02%	633
2021 Q3	$250K	Buy	14,943 +400	+3%	+$7.5K	0.03%	500
2021 Q2	$278K	Buy	+14,543	New	+$281K	0.04%	469

Other funds holding CLPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

MGO One Seven's CLPT Position: Q1 2026 in Review

MGO One Seven increased its ClearPoint Neuro (CLPT) stake by 5.2% in Q1 2026, buying an estimated $12.8K and bringing the position to 20,516 shares worth $187K. The position accounts for ﹤0.01% of the portfolio, ranked #1354.

MGO One Seven first reported a position in CLPT in Q2 2021 and has held it in 10 quarters since. The position peaked at $415K in Q3 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

MGO One Seven held 20,516 shares of ClearPoint Neuro worth $187K as of Q1 2026.
MGO One Seven bought 1,011 ClearPoint Neuro shares in Q1 2026, an estimated $12.8K.
ClearPoint Neuro made up ﹤0.01% of MGO One Seven's portfolio in Q1 2026, its #1354 holding.
MGO One Seven first reported a position in ClearPoint Neuro in Q2 2021 and has held it in 10 quarters since.
MGO One Seven's ClearPoint Neuro position peaked at $415K in Q3 2025.
118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on MGO One Seven's 13F filing for Q1 2026, filed 14 May 2026.